Condition
Pancreatitis Biliary
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Not Yet Recruiting2
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07661498Phase 4Not Yet RecruitingPrimary
Indomethacin for Biliary ERCP Patients
NCT06481007Not Yet Recruiting
ALgerian Cholecystectomy Outcomes and Determinants Study (AL-CODS)
NCT06124989Unknown
Machine learnINg for the rElapse Risk eValuation in Acute Biliary Pancreatitis.
NCT01424215Not ApplicableCompleted
The Use of Fluorescent Imaging for Intraoperative Cholangiogram During Laparoscopic Cholecystectomy
Showing all 4 trials